• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

地中海贫血中的心肌病:从细胞层面到诊断及当前治疗的快速综述

Cardiomyopathy in Thalassemia: Quick Review from Cellular Aspects to Diagnosis and Current Treatments.

作者信息

Ghanavat Majid, Haybar Habib, Pezeshki Seyed Mohammad Sadegh, Shahjahani Mohammad, Jodat Hosein, Elyasi Milad, Saki Najmaldin

机构信息

Child Growth & Development Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.

Atherosclerosis Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.

出版信息

Lab Med. 2020 Mar 10;51(2):143-150. doi: 10.1093/labmed/lmz052.

DOI:10.1093/labmed/lmz052
PMID:32155272
Abstract

BACKGROUND

Cardiomyopathic manifestations induced by continuous blood transfusion are the leading cause of death among patients with thalassemia major (TM). Despite introduction of chelation therapy, heart failure after cardiomyopathic manifestations is still a major threat to patients.

METHODS

We performed a search of relevant English-language literature, retrieving publications from the PubMed database and the Google Scholar search engine (2005-2018). We used "thalassemia major", "cardiomyopathy", "iron overload", "cardiac magnetic resonance T2" "chelation therapy", and "iron burden" as keywords.

RESULTS

The results of the studies we found suggest that cardiac hepcidin is a major regulator of iron homeostasis in cardiac tissue. Unlike previous assumptions, the heart appears to have a limited regeneration capability, originating from a small population of hypoxic cardiomyocytes.

CONCLUSIONS

Oxygen levels determine cardiomyocyte gene-expression patterns. Upregulation of cardiac hepcidin in hypoxia preserves cardiomyocytes from forming out of reactive oxygen species catalyzed by free cellular iron in cardiomyocytes. Using the limited regeneration capacity of cardiac cells and gaining further understanding of the cellular aspects of cardiomyopathic manifestations may help health care professionals to develop new therapeutic strategies.

摘要

背景

持续输血诱发的心肌病表现是重型地中海贫血(TM)患者死亡的主要原因。尽管引入了螯合疗法,但心肌病表现后的心力衰竭仍是患者面临的主要威胁。

方法

我们检索了相关英文文献,从PubMed数据库和谷歌学术搜索引擎(2005 - 2018年)中获取出版物。我们使用“重型地中海贫血”“心肌病”“铁过载”“心脏磁共振T2”“螯合疗法”和“铁负荷”作为关键词。

结果

我们发现的研究结果表明,心脏铁调素是心脏组织中铁稳态的主要调节因子。与先前的假设不同,心脏似乎具有有限的再生能力,源于一小部分缺氧心肌细胞。

结论

氧水平决定心肌细胞基因表达模式。缺氧时心脏铁调素的上调可保护心肌细胞免受心肌细胞内游离细胞铁催化产生的活性氧的影响。利用心脏细胞有限的再生能力并进一步了解心肌病表现的细胞层面,可能有助于医护人员制定新的治疗策略。

相似文献

1
Cardiomyopathy in Thalassemia: Quick Review from Cellular Aspects to Diagnosis and Current Treatments.地中海贫血中的心肌病:从细胞层面到诊断及当前治疗的快速综述
Lab Med. 2020 Mar 10;51(2):143-150. doi: 10.1093/labmed/lmz052.
2
Iron and oxidative stress in cardiomyopathy in thalassemia.地中海贫血性心肌病中铁和氧化应激。
Free Radic Biol Med. 2015 Nov;88(Pt A):3-9. doi: 10.1016/j.freeradbiomed.2015.07.019. Epub 2015 Jul 26.
3
Low serum ferritin levels are misleading for detecting cardiac iron overload and increase the risk of cardiomyopathy in thalassemia patients. The importance of cardiac iron overload monitoring using magnetic resonance imaging T2 and T2*.低血清铁蛋白水平在检测地中海贫血患者的心脏铁过载时具有误导性,并增加了心肌病的风险。使用磁共振成像T2和T2*监测心脏铁过载的重要性。
Hemoglobin. 2006;30(2):219-27. doi: 10.1080/03630260600642542.
4
Physiology and pathophysiology of iron cardiomyopathy in thalassemia.地中海贫血中铁性心肌病的生理学与病理生理学
Ann N Y Acad Sci. 2005;1054:386-95. doi: 10.1196/annals.1345.047.
5
Myocyte damage and loss of myofibers is the potential mechanism of iron overload toxicity in congestive cardiac failure in thalassemia. Complete reversal of the cardiomyopathy and normalization of iron load by deferiprone.心肌细胞损伤和肌纤维丧失是地中海贫血所致充血性心力衰竭中铁过载毒性的潜在机制。去铁酮可使心肌病完全逆转并使铁负荷正常化。
Hemoglobin. 2008;32(1-2):17-28. doi: 10.1080/03630260701726491.
6
Myocardial iron overload assessed by magnetic resonance imaging (MRI)T2* in multi-transfused patients with thalassemia and acquired anemias.MRI T2* 评估铁过载在输血过多的地中海贫血和后天性贫血患者的心肌中的应用。
Eur J Intern Med. 2011 Feb;22(1):62-5. doi: 10.1016/j.ejim.2010.10.005. Epub 2010 Nov 24.
7
Cardiomyopathy associated with iron overload: how does iron enter myocytes and what are the implications for pharmacological therapy?与铁过载相关的心肌病:铁是如何进入心肌细胞的,以及对药物治疗有何影响?
Hemoglobin. 2015;39(1):9-17. doi: 10.3109/03630269.2014.987869. Epub 2015 Jan 9.
8
MRI and iron-overload cardiomyopathy in thalassaemia.地中海贫血中的磁共振成像与铁过载性心肌病
Circulation. 2006 Mar 21;113(11):f43-4.
9
Magnetic resonance imaging during management of patients with transfusion-dependent thalassemia: a single-center experience.输血依赖型地中海贫血患者管理期间的磁共振成像:单中心经验。
Radiol Med. 2018 Aug;123(8):572-576. doi: 10.1007/s11547-018-0889-0. Epub 2018 Apr 16.
10
Iron Chelation Therapy as a Modality of Management.铁螯合疗法作为一种治疗方式。
Hematol Oncol Clin North Am. 2018 Apr;32(2):261-275. doi: 10.1016/j.hoc.2017.12.002. Epub 2018 Jan 17.

引用本文的文献

1
Cardiovascular magnetic resonance in β-thalassemia major: beyond T2.重型β地中海贫血的心血管磁共振成像:超越T2加权成像
Radiol Med. 2024 Dec;129(12):1812-1822. doi: 10.1007/s11547-024-01916-6. Epub 2024 Nov 7.
2
Early Detection of Iron Overload Cardiomyopathy in Transfusion Dependent Thalassemia Patients in Sulaimaniyah City, Iraq.伊拉克苏莱曼尼亚市依赖输血的地中海贫血患者中铁过载心肌病的早期检测
Ther Clin Risk Manag. 2022 Mar 22;18:259-271. doi: 10.2147/TCRM.S354574. eCollection 2022.
3
Ferroptosis in Cardiovascular Diseases: Current Status, Challenges, and Future Perspectives.
心血管疾病中的铁死亡:现状、挑战与未来展望
Biomolecules. 2022 Mar 2;12(3):390. doi: 10.3390/biom12030390.
4
Luspatercept: A Gigantic Step in the Treatment of Transfusion-Dependent β-Thalassemia Patients-a Quick Review.芦帕他赛:治疗输血依赖型β-地中海贫血患者的重大进展——快速综述。
Adv Ther. 2021 Apr;38(4):1732-1745. doi: 10.1007/s12325-021-01663-4. Epub 2021 Mar 4.